Thr366
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr366  -  Nur77 (human)

Site Information
AsPANLLtSLVRAHL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1881000304

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry (in vitro) ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
endometrial cancer ( 1 ) , endometrial adenocarcinoma ( 1 ) , urethral cancer ( 1 )
Relevant cell line - cell type - tissue:
BeWo ( 1 ) , endometrium ( 1 ) , HEK293T (epithelial) ( 1 ) , Ishikawa (endometrial) ( 1 )

Upstream Regulation
Putative in vivo kinases:
MST1 (human) ( 1 )
Kinases, in vitro:
MST1 (human) ( 1 )

Downstream Regulation
Effects of modification on biological processes:
cell adhesion, induced ( 1 ) , signaling pathway regulation ( 1 ) , transcription, induced ( 1 )

References 

1

Cai X, et al. (2023) Mst1-mediated phosphorylation of Nur77 improves the endometrial receptivity in human and mice. EBioMedicine 88, 104433
36623453   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2024 Cell Signaling Technology, Inc.